Treatment of hyperphosphatemia in chronic kidney disease patients

doi:10.3969/j.issn.1004-583X.2016.06.003

Abstract

Abstract:

Hyperphosphatemia is an independent risk factor for mortality in patients with chronic kidney disease (CKD). The prognosis of patients with CKD can be improved by effectively controlling the hyperphosphatemia. At present， the main measure of controlling the level of phosphorus includes limitting dietary phosphorus intake， oral administration of phosphorus and dialysis. Among them， oral intestinal phosphate binding agent is the most convenient and effective method to reduce phosphorus in CKD patients.

Key words: kidney diseases, hyperphosphatemia, dialysis, phosphate binder, treatment

Li Ying. Treatment of hyperphosphatemia in chronic kidney disease patients[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.06.003.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.06.003

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I6/590

[1]	Zhang Feng, Jiang Hongying, Yang Jiao, Li Ruihe, He Ting, Li Meng. Predictive value of red cell distribution width in thoracic aorta calcification in patients with different dialysis modalities [J]. Clinical Focus, 2024, 39(2): 144-148.
[2]	Chen Congshui, Li Yuan, Chen Shufang. Concerning the diagnosis and integrated Chinese and Western medicine treatment of acute biliary pancreatitis in children: A case report [J]. Clinical Focus, 2023, 38(8): 726-730.
[3]	Li Hengnan, Huang Yan, Zhao Yajuan, Hu Guicai. Correlation between serum CTRP5 and left ventricular diastolic dysfunction in patients with continuous ambulatory peritoneal dialysis and its diagnostic value [J]. Clinical Focus, 2023, 38(4): 324-329.
[4]	Wang Siyuan, Wang Li, Wen Xinran, Li Xiaoqing. Multisystem inflammatory syndrome in children after severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection: Two cases report and literature review [J]. Clinical Focus, 2023, 38(12): 1112-1116.
[5]	Dai Jing, Chen Huaqian. Wunderlich syndrome in a patient on haemodialysis with a review of the literature [J]. Clinical Focus, 2023, 38(12): 1107-1111.
[6]	Luo Weigang, Xu Yuzhu, Zhang Lingyan, Wu Xiangyun, Bu Wei, Ren Huiling. Predictive value of the platelet function PFA-200 P2Y on the secondary prevention of acute ischemic stroke with clopidogrel [J]. Clinical Focus, 2023, 38(11): 979-983.
[7]	Gong Zhiqing, Lu Dongmei, Xing Guangqun. The predictive and prognostic potential of serum parathyroid hormone combined with the nutritional status score on peritoneal dialysis catheter-related peritonitis [J]. Clinical Focus, 2023, 38(11): 991-995.
[8]	Wu Haotian, Fan Yuwen, Zhang Xiaolan. Guidelines for Diagnosis and Treatment of Chronic Gastritis in China (2022, Shanghai): An interpretation [J]. Clinical Focus, 2023, 38(10): 926-930.
[9]	Liu Xiangdong, Cai Yandong, Qin Yanjun, Li Yunsong, Li Liang, Gao Ruijiao, Ren Lei, Zhang Yanrong. Exertional rhabdomyolysis complicated with acute renal insufficiency and catheter-related thrombosis: One case and literature review [J]. Clinical Focus, 2022, 37(9): 831-833.
[10]	Liu Peihua, Yang Qian, Liu Zhiqiang, Liang Lu. Continuous veno-venous hemodiafiltration plus activated charcoal hemoperfusion in treatment of multiple organ dysfunction syndrome caused by fish bile poisoning: one case [J]. Clinical Focus, 2022, 37(8): 738-742.
[11]	Zhou Ren, Chen Yating, Zhang Yong. Efficacy and safety of Roxadustat on renal anemia in hemodialysis patients:A meta-analysis [J]. Clinical Focus, 2022, 37(4): 305-310.
[12]	Wang Xiaoqing, Guo Yijia, Tang Yifang, Tang Qin, Yang Jie. The efficacy and safety of different blood pressure target on secondary stroke prevention: A systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(3): 197-203.
[13]	Yu Xin, Liu Zhongyang. Predictive value of lung ultrasonography on adjusted therapeutic regimen for patients with pneumonia [J]. Clinical Focus, 2022, 37(2): 133-136.
[14]	Zhang Hongtao, Wang Zhikui. Renal anemia in patients with maintenance peritoneal dialysis and Related Factors: A single-center study [J]. Clinical Focus, 2022, 37(12): 1099-1103.
[15]	Gong Zhiqing, Chen Yipeng, Lu Dongmei, Xin Lili, Guo Jing, Xing Guangqun. Diagnostic value of monosaccharide in peritoneal dialysis-associated peritonitis [J]. Clinical Focus, 2022, 37(11): 1012-1016.

Treatment of hyperphosphatemia in chronic kidney disease patients

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments